Advanced Parenteral Drug Market: Industry Analysis and Forecast (2021-2027) by Product, Application, and Region

Advanced Parenteral Drug Market size was valued at US$ 3.24 Bn in 2020 and the total revenue is expected to grow at 4.3% through 2021 to 2027, reaching nearly US$ 4.35 Bn.

Advanced Parenteral Drug Market Overview:

Parenteral drugs are administered via the intravenous route of the subcutaneous membrane directly into the bloodstream. Parenteral drugs offered rapid onset of actions as they do not pass through the first-pass metabolism via the liver. They are directly absorbed into the bloodstream and offered a target drug delivery system. Parenteral formulations are highly sterilized to avoid pyrogen contact or any other microbial contamination. Advanced Parenteral Drug Market To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2027. 2020is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done good in lockdown also and specific strategic analysis of those companies is done in the report.

Advanced Parenteral Drug Market Dynamics:

The worldwide advanced parenteral drug market is expected to increase during the forecast timeframe. The demand for sophisticated parenteral drug delivery systems has increased as the number of parenteral drug administrations has steadily increased. Parenteral drug administration is the most popular method of drug delivery after oral administration because of the benefits associated with it, such as increased bioavailability of the active pharmaceutical ingredient and a narrow therapeutic index. Parenteral drug delivery devices are used to give medications through methods other than the oral route. Innovative devices that enable advanced medication targeting and controlled release of parenteral medicines have been developed as a result of technological advancements in the field of parenteral drug delivery systems. Parenteral formulations, particularly intravenous ones, allow for direct medication entry into the bloodstream and quick therapeutic action at specified target areas. In severe medical situations such as nausea, unconsciousness, and clinical emergencies, parenteral drug carriers outperform alternative dosage forms. Parenteral medications are seeing rising demand as the pharmaceutical industry evolves, most notably stimulated by the coronavirus (COVID-19) and its consequences for drug demand, distribution, and the supply chain. The format, whether injected intravenously, intramuscularly or subcutaneously, opens up new and important pathways for drug administration due to several advantageous safety and effectiveness characteristics. Hence, these key elements are likely to support the growth of the market.

Advanced Parenteral Drug Market Segment Analysis:

The Prefilled Syringes segment is dominating the Product segment of the Advanced Parenteral Drug Market: A pre-filled syringe is a disposable syringe already loaded with a pharmaceutical ingredient. The solution comes in the form of a pre-filled syringe that already has the liquid for injection. A pre-filled syringe is a single dose of medication that has been fitted with a needle by the manufacturer. Due to the general increased safety, convenience of administration, precise dosage, and low chance of contamination, prefilled syringes are likely to be the fastest-growing segment of this market. In addition, rapid advancements in the field of biosimilars and biological products, as well as an increase in the use of controlled drug delivery systems, are likely to drive market expansion throughout the projection period. By using a sustained release drug delivery mechanism, an advanced drug delivery device can reduce the total number of injections in medication therapy, which is both medically and economically beneficial. In additions benefits offered by prefilled syringes such as sterility, affordability is likely to support the growth of the market. Advanced Parenteral Drug Market The Cardiovascular Agent segment is considered to supplement the growth of the Advanced Parenteral Drug Market. Cardiovascular Agents are dominating the application segment of the advanced parenteral drug. Arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke are among medical diseases that can be treated with cardiovascular agents. Further, growing heart diseases is likely to boost the growth of cardiovascular agent globally. More, heart disease is a leading cause of mortality among men and women and people of the most cultural and traditional groups. Nearly 18.6 million people died of cardiovascular disease globally in 2019, this represents a 17.3 % growth over the previous ten years. Hence, the increasing demand for a cardiovascular agent is likely to hit the market expansion in the forecast time frame.

Advanced Parenteral Drug Market Regional Insights:

North America is likely to boost the growth of the Advanced Parenteral Drug Market. The North American market is projected to have a marked largest market share of 38% in 2019. Owing to increasing acceptance of technologically advanced healthcare systems and rising patient awareness levels. Heart disease is a leading cause of death in the US and is likely to support the expansion of advanced parenteral drugs in the regional market. Between 2018 and 2019, the United States invested USD 469 billion in heart disease. This includes the costs of medical services, medications, and lost productivity as a result of mortality. In every 36 seconds, one person is dying due to cardiovascular disease in the US. Moreover, various other medical conditions and immobile lifestyles choices can also be responsible to put populations of North America at high risk of heart diseases including diabetes, unhealthy lifestyle, excessive alcohol consumptions, and obesity. The objective of the report is to present a comprehensive analysis of the Advanced Parenteral Drug Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Advanced Parenteral Drug Market dynamics, structure by analyzing the market segments and project the Advanced Parenteral Drug Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Advanced Parenteral Drug Market make the report investor’s guide.

Advanced Parenteral Drug Market Scope: Inquire before buying

Advanced Parenteral Drug Market

Advanced Parenteral Drug Market, by Region

• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America

Advanced Parenteral Drug Market Key Player

Amgen IncorporatedAstraZeneca plc • Abbott Laboratories • Baxter International Incorporated • Becton • Dickinson, and Company • Bristol-Myers Squibb Company • Beximco Pharma • AptarGroup Incorporated • Novartis AG • Pfizer Incorporated • GlaxoSmithKline Plc • Roche Holding Limited • AptarGroup Incorporated • Squibb Company • Boston Scientific Corporation • Pfizer.

FAQs:

1. What is the Advanced Parenteral Drug market value in 2020? Ans: Advanced Parenteral Drug market value in 2020 was estimated as 3.24 Billion USD. 2. What is the Advanced Parenteral Drug market growth? Ans: The Advanced Parenteral Drug market is anticipated to grow with a CAGR of 4.3% in the forecast period and is likely to reach USD 4.35 Billion by the end of 2027. 3. Which Application segment is expected to dominate the Advanced Parenteral Drug market during the forecast period? Ans: The Cardiovascular agent segment is projected to lead the market growth owing to an increase in unhealthy lifestyle patterns and lack of movement, and excessive consumption of Alcohol. 4. Who are the key players in the Advanced Parenteral Drug market? Ans: Some key players operating in the Advanced Parenteral Drug market include Amgen Incorporated, AstraZeneca plc, Abbott Laboratories, Baxter International Incorporated, Becton, Dickinson, and Company, Bristol-Myers Squibb Company, AptarGroup Incorporated, Novartis AG Pfizer Incorporated, GlaxoSmithKline Plc, and Roche Holding Limited. 5. What is the key driving factor for the growth of the Advanced Parenteral Drug market? Ans: Key factors that are driving the Advanced Parenteral Drug market growth include a rise in demand for parenteral formulations and an increase in the demand due to their fast onset of action.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Advanced Parenteral Drug Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2020 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Advanced Parenteral Drug Market 3.4. Geographical Snapshot of the Advanced Parenteral Drug Market, By Manufacturer share 4. Advanced Parenteral Drug Market Overview, 2020-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Advanced Parenteral Drug Market 5. Supply Side and Demand Side Indicators 6. Advanced Parenteral Drug Market Analysis and Forecast, 2020-2027 6.1. Advanced Parenteral Drug Market Size & Y-o-Y Growth Analysis. 7. Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 7.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 7.1.1. IV Catheters 7.1.2. Injector Cartridges 7.1.3. Prefilled Syringes 7.1.4. Hypodermic Syringes 7.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 7.2.1. Cardiovascular Agents 7.2.2. Respiratory Agents 7.2.3. Gastrointestinal Agents 7.2.4. Central Nervous System Agents 7.2.5. Nutritional Agents 7.2.6. Anti-Infective Agents 8. Advanced Parenteral Drug Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2020-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 9.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 9.1.1. IV Catheters 9.1.2. Injector Cartridges 9.1.3. Prefilled Syringes 9.1.4. Hypodermic Syringes 9.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 9.2.1. Cardiovascular Agents 9.2.2. Respiratory Agents 9.2.3. Gastrointestinal Agents 9.2.4. Central Nervous System Agents 9.2.5. Nutritional Agents 9.2.6. Anti-Infective Agents 10. North America Advanced Parenteral Drug Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 11.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 11.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 12. Canada Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 12.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 12.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 13. Mexico Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 13.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 13.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 14. Europe Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 14.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 14.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 15. Europe Advanced Parenteral Drug Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 16.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 16.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 17. France Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 17.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 17.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 18. Germany Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 18.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 18.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 19. Italy Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 19.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 19.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 20. Spain Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 20.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 20.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 21. Sweden Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 21.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 21.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 22. CIS Countries Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 22.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 22.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 23. Rest of Europe Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 23.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 23.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 24. Asia Pacific Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 24.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 24.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 25. Asia Pacific Advanced Parenteral Drug Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 26.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 26.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 27. India Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 27.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 27.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 28. Japan Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 28.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 28.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 29. South Korea Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 29.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 29.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 30. Australia Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 30.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 30.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 31. ASEAN Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 31.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 31.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 32. Rest of Asia Pacific Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 32.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 32.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 33. Middle East Africa Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 33.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 33.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 34. Middle East Africa Advanced Parenteral Drug Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 35.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 35.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 36. GCC Countries Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 36.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 36.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2020-2027 37.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 37.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 38. Nigeria Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 38.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 38.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 39. Rest of ME&A Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 39.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 39.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 40. South America Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 40.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 40.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 41. South America Advanced Parenteral Drug Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 42.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 42.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 43. Argentina Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 43.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 43.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 44. Rest of South America Advanced Parenteral Drug Market Analysis and Forecasts, 2020-2027 44.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 44.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Advanced Parenteral Drug Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Pfizer (Hospira) 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. Amgen Incorporated 45.3.3. AstraZeneca plc 45.3.4. Abbott Laboratories 45.3.5. Baxter International Incorporated 45.3.6. Becton 45.3.7. Dickinson, and Company 45.3.8. Bristol-Myers Squibb Company 45.3.9. AptarGroup Incorporated 45.3.10. Pfizer Incorporated 45.3.11. GlaxoSmithKline Plc 45.3.12. Roche Holding Limited 45.3.13. AptarGroup Incorporated 45.3.14. Squibb Company 45.3.15. Boston Scientific Corporation 45.3.16. GlaxoSmithKline plc 45.3.17. Roche Holding Limited 45.3.18. Novartis AG 46. Primary Key Insights

About This Report

Report ID 121319
Category Healthcare
Published Date Sep 2021
Updated Date
  • INQUIRE BEFORE BUYING